Urocortin, human

CAS No. 176591-49-4

Urocortin, human ( ?Urocortin (human); Human urocortin; Human urocortin 1; Human urocortin I )

Catalog No. M23791 CAS No. 176591-49-4

Urocortin (Ucn) is a 40 amino acid peptide which is closely related to corticotrophin-releasing factor (CRF).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 503 In Stock
10MG 707 In Stock
25MG 1107 In Stock
50MG 1494 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Urocortin, human
  • Note
    Research use only, not for human use.
  • Brief Description
    Urocortin (Ucn) is a 40 amino acid peptide which is closely related to corticotrophin-releasing factor (CRF).
  • Description
    Urocortin (Ucn) is a 40 amino acid peptide which is closely related to corticotrophin-releasing factor (CRF).
  • Synonyms
    ?Urocortin (human); Human urocortin; Human urocortin 1; Human urocortin I
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CRF2?
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    176591-49-4
  • Formula Weight
    4696.3
  • Molecular Formula
    C204H337N63O64
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Reul JM, et al. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol. 2002 Feb;2(1):23-33.
molnova catalog
related products
  • (-)-MK 801 Maleate

    MK-801 is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes.

  • Curculigoside

    Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.

  • NPB

    NPB is a potent BAD phosphorylation inhibitor(at Ser99,IC50 of 0.41 μM.)